Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
11.07
+0.02 (0.18%)
At close: Sep 16, 2026, 4:00 PM EDT
11.04
-0.03 (-0.27%)
After-hours: Sep 16, 2026, 4:10 PM EDT

Benitec Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-45.55-37.92-21.75-19.56-18.21
Depreciation & Amortization
0.480.40.340.380.39
Loss (Gain) From Sale of Investments
--000.01
Stock-Based Compensation
26.4117.430.830.450.87
Other Operating Activities
--0.76---
Change in Accounts Receivable
0.030.2-0.18-0.050
Change in Accounts Payable
3.27-2.380.941.361.09
Change in Other Net Operating Assets
-1.17-0.550.41-0.59-0.05
Operating Cash Flow
-16.52-23.59-19.4-18.01-15.9
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-0.11-0.02-0.18-0-0.01
Investing Cash Flow
-0.11-0.02-0.18-0-0.01

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Issuance of Common Stock
105.2472.873.9217.88-
Other Financing Activities
-6.27-2.32-5.89-1.87-
Financing Cash Flow
98.9870.4968.0316.02-

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
-0.130.05-0.010.410.2
Net Cash Flow
82.2346.9348.44-1.59-15.71

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-16.62-23.61-19.58-18.01-15.91
Free Cash Flow Growth
-----
Free Cash Flow Margin
----24017.33%-21797.26%
Free Cash Flow Per Share
-0.36-0.65-1.07-13.00-33.10
Levered Free Cash Flow
-2.75-11.46-11.68-10.19-8.72
Unlevered Free Cash Flow
-2.75-11.46-11.68-10.16-8.7

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Change in Working Capital
2.14-2.731.170.711.04
SEC Filings: 10-K · 10-Q